4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-027781
President and CEO sold 16,149 shares at $5.02 ($81,068)
- President and CEO acquired 16,149 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Doerfler Douglas · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,149 | $0.04 | $646 | 349,346 | D |
| 2023-05-03 | Sale : show line 2 in the form 10b5-1 | −16,149 | $5.02 | $81,068 | 333,197 | D |
| Open-market sales · 16,149 sh · avg $5.02 · $81,068 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −16,149 | 308,931 | D |
Loading xslF345X04/doc4.xml…